Demopulos Peter A MD 4

What Happened Dr. Peter A. Demopulos, a non-employee director of Omeros Corporation (OMER), was granted an option covering 15,000 shares on June 18, 2026. The Form 4 reports this derivative award at an acquisition price of $0.00 (reflecting an option grant rather than a cash purchase). The filing does not state the option strike price or immediate monetary value.

Key Details

• Transaction date: 2026-06-18 (reported on Form 4 filed 2026-06-22).
• Transaction type/code: A — Award/Grant (derivative security).
• Shares/options granted: option to purchase 15,000 shares; acquisition value shown as $0.00.
• Vesting: The option will fully vest and become exercisable the day before the 2027 annual meeting, provided Demopulos remains a director (per footnote).
• Policy: Grant was made under Omeros’ non-employee director compensation policy, which automatically awards this option to qualifying directors after the annual meeting.
• Shares owned after transaction: the filing does not disclose the reporting person's total post-transaction beneficial ownership.
• Timeliness: Form 4 was filed within the normal two-business-day window (transaction 6/18, filed 6/22).

Context This is a routine director compensation award, not an open-market buy or sale. Such grants are common for non-employee directors and do not by themselves indicate an immediate buy/sell signal for investors. The economic impact to Demopulos (and to shareholders) will depend on the option's strike price, future vesting, and whether/when the option is exercised or shares are sold.